PSMA PET/CT for treatment response evaluation at predefined time points is superior to PSA response for predicting survival in metastatic castration-resistant prostate cancer patients.
第一作者:
F,Kleiburg
第一单位:
Biomedical Photonic Imaging Group, University of Twente, Enschede, the Netherlands; Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Centre, Leiden, the Netherlands. Electronic address: F.Kleiburg@lumc.nl.
作者:
医学主题词
人类(Humans);男(雄)性(Male);老年人(Aged);前列腺特异抗原(Prostate-Specific Antigen);回顾性研究(Retrospective Studies);中年人(Middle Aged);治疗结果(Treatment Outcome);放射性药物(Radiopharmaceuticals);老年人, 80以上(Aged, 80 and over);存活率(Survival Rate);烟酰胺(Niacinamide);寡肽类(Oligopeptides)
DOI
10.1016/j.ejrad.2024.111774
PMID
39442347
发布时间
2024-12-03
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



